Clinical Trial

Early administration of convalescent plasma in people over 50 years of age with mild to moderate COVID-19 disease may slow disease progression and decrease the severity of symptoms.

This study aims to demonstrate efficacy of Montelukast for patients with persistent COVID-19 to help them improve their quality of life.

Collaborate with ANTICOV study to treat COVID-19 in Africa.

Solidarity is an international clinical trial to evaluate the effect of a number of drugs for the treatment of COVID-19.

This study aims to determine the validity of a new method to detect COVID-19 by characterising molecules in exhaled air.

Convalescent plasma with anti-SARS-CoV-2 antibodies appears to be a very promising approach in the context of protracted COVID-19 symptoms in patients unable to mount a specific humoral response to SARS-CoV-2.

This clinical trial aims to explore the efficacy of allogeneic mesenchymal cells from umbilical cord tissue in patients with severe COVID-19 lung disease.

Can sex hormones help men survive COVID-19? This study assesses the safety and efficacy of progesterone for the treatment of COVID-19 in hospitalized men.

Open, randomized, adaptive, phase III clinical trial study to evaluate the efficacy of various pharmacological alternatives in the treatment of severe infection in COVID-19 pediatric patients.

Clinical trial designed to determine if the vaccine candidate, AZD1222, can prevent symptomatic COVID-19.

The STROMA-CoV trial aims to treat patients with severe acute respiratory syndrome due to SARS-CoV-2 by intravenous administration of umbilical cord mesenchymal stromal cells.

The study aims to identify plants based on traditional knowledge that can reduce or eliminate symptoms and the length of illness in non-hospitalised patients with COVID-19.